Whitegate Investment Counselors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
3,322
+9
+0.3% +$923 0.09% 51
2026
Q1
$362K Buy
3,313
+7
+0.2% +$667 0.12% 50
2025
Q4
$268K Buy
3,306
+8
+0.2% +$689 0.08% 55
2025
Q3
$289K Buy
3,298
+7
+0.2% +$625 0.1% 54
2025
Q2
$273K Buy
3,291
+8
+0.2% +$669 0.09% 57
2025
Q1
$275K Buy
3,283
+8
+0.2% +$744 0.1% 55
2024
Q4
$302K Buy
3,275
+5
+0.2% +$481 0.1% 56
2024
Q3
$304K Buy
3,270
+6
+0.2% +$520 0.08% 58
2024
Q2
$269K Buy
3,264
+7
+0.2% +$514 0.08% 57
2024
Q1
$216K Buy
+3,257
New +$201K 0.06% 57
2023
Q3
Sell
-3,233
Closed -$218K 62
2023
Q2
$218K Buy
+3,233
New +$197K 0.07% 54

Other funds holding LMAT

Whitegate Investment Counselors's LMAT Position: Q2 2026 in Review

Whitegate Investment Counselors increased its LeMaitre Vascular (LMAT) stake by 0.27% in Q2 2026, buying an estimated $923 and bringing the position to 3,322 shares worth $319K. The position accounts for 0.09% of the portfolio, ranked #51.

Whitegate Investment Counselors first reported a position in LMAT in Q2 2023 and has held it in 11 quarters since. The position peaked at $362K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Whitegate Investment Counselors held 3,322 shares of LeMaitre Vascular worth $319K as of Q2 2026.
  • Whitegate Investment Counselors bought 9 LeMaitre Vascular shares in Q2 2026, an estimated $923.
  • LeMaitre Vascular made up 0.09% of Whitegate Investment Counselors's portfolio in Q2 2026, its #51 holding.
  • Whitegate Investment Counselors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 11 quarters since.
  • Whitegate Investment Counselors's LeMaitre Vascular position peaked at $362K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Whitegate Investment Counselors's 13F filing for Q2 2026, filed 10 Aug 2026.